annual CFI:
$114.96M+$275.43M(+171.64%)Summary
- As of today (September 16, 2025), MLYS annual cash flow from investing activities is $114.96 million, with the most recent change of +$275.43 million (+171.64%) on December 31, 2024.
- During the last 3 years, MLYS annual CFI has risen by +$114.96 million (+100.00%).
- MLYS annual CFI is now at all-time high.
Performance
MLYS Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
-$42.88M+$49.99M(+53.83%)Summary
- As of today (September 16, 2025), MLYS quarterly cash flow from investing activities is -$42.88 million, with the most recent change of +$49.99 million (+53.83%) on June 30, 2025.
- Over the past year, MLYS quarterly CFI has dropped by -$50.62 million (-654.30%).
- MLYS quarterly CFI is now -151.31% below its all-time high of $83.57 million, reached on December 31, 2024.
Performance
MLYS quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
$27.42M-$50.62M(-64.86%)Summary
- As of today (September 16, 2025), MLYS TTM cash flow from investing activities is $27.42 million, with the most recent change of -$50.62 million (-64.86%) on June 30, 2025.
- Over the past year, MLYS TTM CFI has increased by +$79.72 million (+152.43%).
- MLYS TTM CFI is now -76.15% below its all-time high of $114.96 million, reached on December 31, 2024.
Performance
MLYS TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
MLYS Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +171.6% | -654.3% | +152.4% |
| 3 y3 years | +100.0% | -100.0% | +100.0% |
| 5 y5 years | +100.0% | - | - |
MLYS Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +171.6% | -151.3% | +69.4% | -76.2% | +115.4% |
| 5 y | 5-year | at high | +171.6% | -151.3% | +69.4% | -76.2% | +115.4% |
| alltime | all time | at high | +171.6% | -151.3% | +69.4% | -76.2% | +115.4% |
MLYS Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$42.88M(-53.8%) | $27.42M(-64.9%) |
| Mar 2025 | - | -$92.88M(-211.1%) | $78.03M(-32.1%) |
| Dec 2024 | $114.96M(-171.6%) | $83.57M(+5.0%) | $114.96M(+393.4%) |
| Sep 2024 | - | $79.61M(+929.0%) | $23.30M(-144.6%) |
| Jun 2024 | - | $7.74M(-113.8%) | -$52.30M(-31.3%) |
| Mar 2024 | - | -$55.95M(+591.7%) | -$76.17M(-52.5%) |
| Dec 2023 | -$160.47M | -$8.09M(-301.9%) | -$160.47M(+56.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | $4.01M(-124.8%) | -$102.38M(-42.5%) |
| Jun 2023 | - | -$16.14M(-88.5%) | -$178.15M(+10.0%) |
| Mar 2023 | - | -$140.25M(-380.5%) | -$162.01M(+644.6%) |
| Dec 2022 | -$21.76M(<-9900.0%) | $50.00M(-169.7%) | -$21.76M(-69.7%) |
| Sep 2022 | - | -$71.76M(<-9900.0%) | -$71.76M(<-9900.0%) |
| Jun 2022 | - | $0.00 | $0.00 |
| Dec 2021 | $0.00(0.0%) | - | - |
| Dec 2020 | $0.00 | - | - |
FAQ
- What is Mineralys Therapeutics, Inc. annual cash flow from investing activities?
- What is the all time high annual CFI for Mineralys Therapeutics, Inc.?
- What is Mineralys Therapeutics, Inc. annual CFI year-on-year change?
- What is Mineralys Therapeutics, Inc. quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Mineralys Therapeutics, Inc.?
- What is Mineralys Therapeutics, Inc. quarterly CFI year-on-year change?
- What is Mineralys Therapeutics, Inc. TTM cash flow from investing activities?
- What is the all time high TTM CFI for Mineralys Therapeutics, Inc.?
- What is Mineralys Therapeutics, Inc. TTM CFI year-on-year change?
What is Mineralys Therapeutics, Inc. annual cash flow from investing activities?
The current annual CFI of MLYS is $114.96M
What is the all time high annual CFI for Mineralys Therapeutics, Inc.?
Mineralys Therapeutics, Inc. all-time high annual cash flow from investing activities is $114.96M
What is Mineralys Therapeutics, Inc. annual CFI year-on-year change?
Over the past year, MLYS annual cash flow from investing activities has changed by +$275.43M (+171.64%)
What is Mineralys Therapeutics, Inc. quarterly cash flow from investing activities?
The current quarterly CFI of MLYS is -$42.88M
What is the all time high quarterly CFI for Mineralys Therapeutics, Inc.?
Mineralys Therapeutics, Inc. all-time high quarterly cash flow from investing activities is $83.57M
What is Mineralys Therapeutics, Inc. quarterly CFI year-on-year change?
Over the past year, MLYS quarterly cash flow from investing activities has changed by -$50.62M (-654.30%)
What is Mineralys Therapeutics, Inc. TTM cash flow from investing activities?
The current TTM CFI of MLYS is $27.42M
What is the all time high TTM CFI for Mineralys Therapeutics, Inc.?
Mineralys Therapeutics, Inc. all-time high TTM cash flow from investing activities is $114.96M
What is Mineralys Therapeutics, Inc. TTM CFI year-on-year change?
Over the past year, MLYS TTM cash flow from investing activities has changed by +$79.72M (+152.43%)